Related Experiment Videos
[Efficacy of a disease management programme in asthma]
W Petro1, J M V D Schulenburg, W Greiner
1Klinik Bad Reichenhall, Salzburger Str. 8-11, 83435 Bad Reichenhall.
Pneumologie (Stuttgart, Germany)
|February 23, 2005
Summary
Disease Management Programmes (DMP) significantly improved asthma patients' health and lung function. This asthma management approach also reduced overall treatment costs and symptoms.
Area of Science:
- Pulmonology
- Healthcare Management
Context:
- Chronic disease management programs aim to enhance patient care and control healthcare costs.
- Asthma patients require continuous monitoring and tailored treatment plans for optimal outcomes.
Purpose:
- To evaluate the effectiveness of a Disease Management Programme (DMP) for asthma patients.
- To assess the impact of DMP on quality of life, symptoms, lung function, and treatment costs.
Summary:
- Patients in the DMP showed statistically significant improvements in quality of life (FLA, EuroQuol) and asthma symptoms compared to the control group.
- Lung function (FEV1) increased in the DMP group, while it declined in the control group. Daily FEV1 measurements at home also showed improvement.
- Direct treatment costs were lower in the DMP group, with significantly reduced inpatient respiratory-related expenses, despite higher indirect costs due to increased disability.
Impact:
- The tested DMP for asthmatics led to significant improvements in health status, symptom control, and lung function.
- This asthma management strategy demonstrated a reduction in direct treatment costs, making it a potentially cost-effective approach for managing chronic respiratory conditions.